View Archive »
About The Cover
The cover for issue 61 of Oncotarget features Figure 3, "The effect of loss of CD38 on blood vessels, necrotic area, peritumoral area and amount of CAFs in late stage tumors effect on blood vessels density," by Baruch, et al.
Table of Contents
Stem cells: a window of opportunity in low-dimensional EMT space
Stem cells: a window of opportunity in low-dimensional EMT space |
|
https://doi.org/10.18632/oncotarget.25852
Qing Nie
|
| 31790-31791 |
A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion
A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion |
|
https://doi.org/10.18632/oncotarget.25872
Takenobu Katagiri
|
| 31792-31792 |
A new twist to V-ATPases and cancer
A new twist to V-ATPases and cancer |
|
https://doi.org/10.18632/oncotarget.25883
Michael Forgac
|
| 31793-31794 |
Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists
Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists |
|
https://doi.org/10.18632/oncotarget.25841
Koen F. de Geus,
Charlotte Maggen,
Jorine de Haan,
and Frédéric Amant
|
| 31795-31796 |
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis |
|
https://doi.org/10.18632/oncotarget.25737
Bar Ben Baruch,
Eran Blacher,
Einav Mantsur,
Hila Schwartz,
Hananya Vaknine,
Neta Erez,
and Reuven Stein
|
| 31797-31811 |
Immunologically effective dose: a practical model for immunoradiotherapy
Immunologically effective dose: a practical model for immunoradiotherapy |
|
https://doi.org/10.18632/oncotarget.25746
Raphaël Serre,
Fabrice Barlesi,
Xavier Muracciole,
and Dominique Barbolosi
|
| 31812-31819 |
Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX |
|
https://doi.org/10.18632/oncotarget.25806
Theodore Vougiouklakis,
Vassiliki Saloura,
Jae-Hyun Park,
Naofumi Takamatsu,
Takashi Miyamoto,
Yusuke Nakamura,
and Yo Matsuo
|
| 31820-31831 |
LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) |
|
https://doi.org/10.18632/oncotarget.25835
Yan Ting Hee,
Junli Yan,
Dean Nizetic,
and Wee-Joo Chng
|
| 31832-31841 |
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors |
|
https://doi.org/10.18632/oncotarget.25867
Katia Corano Scheri,
Erica Leonetti,
Luigi Laino,
Vincenzo Gigantino,
Luisa Gesualdi,
Paola Grammatico,
Mariano Bizzarri,
Renato Franco,
J. Wolter Oosterhuis,
Hans Stoop,
Leendert H.J. Looijenga,
Giulia Ricci,
and Angela Catizone
|
| 31842-31860 |
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study |
|
https://doi.org/10.18632/oncotarget.25870
Gemma Bruera,
Silvia Massacese,
Stefania Candria,
Antonio Galvano,
Rosa Manetta,
Aldo Victor Giordano,
Sergio Carducci,
Alessandra Di Sibio,
Eugenio Ciacco,
Antonio Russo,
Enrico Ricevuto,
and on behalf of Oncology Network ASL1 Abruz, Italy
|
| 31861-31876 |
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
|
https://doi.org/10.18632/oncotarget.25874
Marina Cazzaniga,
Claudio Verusio,
Mariangela Ciccarese,
Alberto Fumagalli,
Donata Sartori,
Maria Rosaria Valerio,
Mario Airoldi,
Gabriella Moretti,
Corrado Ficorella,
Valentina Arcangeli,
Lucrezia Diodati,
Alberto Zambelli,
Antonio Febbraro,
Daniele Generali,
Mirco Pistelli,
Ornella Garrone,
Antonino Musolino,
Patrizia Vici,
Michela Maur,
Lucia Mentuccia,
Nicla La Verde,
Giulia Bianchi,
Salvatore Artale,
Livio Blasi,
Matilde Piezzo,
Francesco Atzori,
Anna Turletti,
Chiara Benedetto,
Maria Concetta Cursano,
Alessandra Fabi,
Vittorio Gebbia,
Alessio Schirone,
Raffaella Palumbo,
Antonella Ferzi,
Antonio Frassoldati,
Claudio Scavelli,
Luca Clivio,
and Valter Torri on behalf of The EVA Study Group
|
| 31877-31887 |
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma |
|
https://doi.org/10.18632/oncotarget.25879
Mohammad Krayem,
Ahmad Najem,
Fabrice Journe,
Renato Morandini,
François Sales,
Ahmad Awada,
and Ghanem E. Ghanem
|
| 31888-31903 |
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy |
|
https://doi.org/10.18632/oncotarget.25881
Akemi Sato,
Chiho Nakashima,
Tomonori Abe,
Junichi Kato,
Mitsuharu Hirai,
Tomomi Nakamura,
Kazutoshi Komiya,
Shinya Kimura,
Eisaburo Sueoka,
and Naoko Sueoka-Aragane
|
| 31904-31914 |
Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results
Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results |
|
https://doi.org/10.18632/oncotarget.25739
Alberto Ocaña,
Eitan Amir,
and Atanasio Pandiella
|
| 31915-31919 |
Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics
Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics |
|
https://doi.org/10.18632/oncotarget.25886
Kumari Asha,
and Neelam Sharma-Walia
|
| 31920-31936 |
Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies
Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies |
|
https://doi.org/10.18632/oncotarget.25969
Shaojin Zhang,
Zhankui Jia,
Zechen Yan,
and Jinjian Yang
|
| 31937-31937 |
Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer
Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer |
|
https://doi.org/10.18632/oncotarget.25970
Jung Ki Jo,
Jong Jin Oh,
Yong Tae Kim,
Hong Sang Moon,
Hong Yong Choi,
Seunghyun Park,
Jin-Nyoung Ho,
Sungroh Yoon,
Hae Young Park,
and Seok-Soo Byun
|
| 31938-31938 |
